Promising targets and drugs in rheumatoid arthritis: a module-based and cumulatively scoring approach

Xingyan Li1, Yejing Yang1, Guili Sun2

  • 1Department of Bone and Joint Surgery, The Third Affiliated Hospital of Guangxi Medical University, Nanning, China.

Bone & Joint Research
|September 14, 2020
PubMed
Abstract

Insights

This study developed a novel method to identify therapeutic targets and drugs for rheumatoid arthritis (RA). Key genes and potential drugs like niclosamide were found, offering new treatment strategies for RA.

Area of Science:

  • Rheumatoid Arthritis Research
  • Immunology
  • Genomics
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) is a systemic autoimmune disease causing inflammation and joint destruction.
  • Current RA treatments have limited efficacy and significant side effects for some patients.
  • Novel therapeutic targets and drugs are needed for effective RA management.

Purpose of the Study:

  • To screen candidate therapeutic targets for rheumatoid arthritis (RA) using a novel approach.
  • To identify promising drugs for RA treatment.
  • To provide methodological insights into target and drug screening for complex diseases.

Main Methods:

  • Developed a module-based, cumulatively scoring approach integrating weighted gene co-expression network analysis (WGCNA) and Connectivity Map (CMap).
  • Applied this method to high-throughput datasets to identify RA-related biological modules and key genes.
  • Screened candidate drugs based on gene signatures within identified RA-related modules.

Main Results:

  • Identified four significant RA-related modules, highlighting immune and infection pathways.
  • Recognized key hub genes including HLA-DMA, HLA-DPB1, BTK, CD4, and PTPRC, crucial for RA pathogenesis.
  • Identified long noncoding RNAs (lncRNAs) like FAM30A and NEAT1 as important interactors.
  • Screened niclosamide and other compounds (T-type calcium channel blockers, IKK inhibitors, etc.) as promising drugs with high specificity and broad coverage for RA modules.

Conclusions:

  • The study successfully identified promising therapeutic targets and candidate drugs for rheumatoid arthritis.
  • The novel methodological approach offers a valuable tool for future target and drug discovery.
  • Findings contribute to a better understanding of RA pathogenesis and potential treatment strategies.

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.7K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
160
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
346
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.6K